Francisco Morandeira

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Paul Bastard, Adrian Gervais, Jérémie Rosain et al. · Science Immunology · 2021 · 631 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Jérémy Manry, Paul Bastard, Adrian Gervais et al. · Proceedings of the National Academy of Sciences · 2022 · 193 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona

Xavier Solanich, Raül Rigo‐Bonnin, Victor-David Gumucio et al. · Journal of Clinical Immunology · 2021 · 106 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Daniela Matuozzo, Estelle Talouarn, Astrid Marchal et al. · Genome Medicine · 2023 · 77 citations · Full text

Life Sciences, Genetics, Immunology +17

The effect of simvastatin on inflammatory cytokines in community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial

Diego Viasus, Carolina García‐Vidal, Antonella F. Simonetti et al. · BMJ Open · 2015 · 55 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +16